These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35418909)

  • 1. A Single Belief-Changing Psychedelic Experience Is Associated With Increased Attribution of Consciousness to Living and Non-living Entities.
    Nayak SM; Griffiths RR
    Front Psychol; 2022; 13():852248. PubMed ID: 35418909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Belief changes associated with psychedelic use.
    Nayak SM; Singh M; Yaden DB; Griffiths RR
    J Psychopharmacol; 2023 Jan; 37(1):80-92. PubMed ID: 36317643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychedelics alter metaphysical beliefs.
    Timmermann C; Kettner H; Letheby C; Roseman L; Rosas FE; Carhart-Harris RL
    Sci Rep; 2021 Nov; 11(1):22166. PubMed ID: 34815421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study.
    Nayak SM; White SH; Hilbert SN; Lowe MX; Jackson H; Griffiths RR; Garcia-Romeu A; Yaden DB
    J Psychoactive Drugs; 2024 May; ():1-10. PubMed ID: 38715376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Responses to Psychedelics: A Prospective Study.
    Haijen ECHM; Kaelen M; Roseman L; Timmermann C; Kettner H; Russ S; Nutt D; Daws RE; Hampshire ADG; Lorenz R; Carhart-Harris RL
    Front Pharmacol; 2018; 9():897. PubMed ID: 30450045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).
    Nour MM; Evans L; Nutt D; Carhart-Harris RL
    Front Hum Neurosci; 2016; 10():269. PubMed ID: 27378878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.
    Sweeney MM; Nayak S; Hurwitz ES; Mitchell LN; Swift TC; Griffiths RR
    PLoS One; 2022; 17(8):e0271926. PubMed ID: 36001643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model.
    Wießner I; Falchi M; Palhano-Fontes F; Feilding A; Ribeiro S; Tófoli LF
    Psychol Med; 2023 Mar; 53(4):1151-1165. PubMed ID: 34253268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturalism and the hard problem of mysticism in psychedelic science.
    Jylkkä J
    Front Psychol; 2024; 15():1112103. PubMed ID: 38558777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelics, Meditation, and Self-Consciousness.
    Millière R; Carhart-Harris RL; Roseman L; Trautwein FM; Berkovich-Ohana A
    Front Psychol; 2018; 9():1475. PubMed ID: 30245648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey.
    Kuc J; Kettner H; Rosas F; Erritzoe D; Haijen E; Kaelen M; Nutt D; Carhart-Harris RL
    Psychopharmacology (Berl); 2022 May; 239(5):1425-1440. PubMed ID: 34734314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Predicts Beneficial Outcomes in Psychedelic Use? A Quantitative Content Analysis of Psychedelic Health Outcomes.
    Acevedo EC; Uhler S; White KP; Al-Shawaf L
    J Psychoactive Drugs; 2024 Feb; ():1-10. PubMed ID: 38341606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects.
    Martial C; Carhart-Harris R; Timmermann C
    Neurosci Conscious; 2024; 2024(1):niae033. PubMed ID: 39220326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.
    Sekula AD; Downey L; Puspanathan P
    Front Psychol; 2022; 13():813746. PubMed ID: 35310225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts.
    Graziosi M; Singh M; Nayak SM; Yaden DB
    J Psychoactive Drugs; 2023; 55(5):558-569. PubMed ID: 37679890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mystical and Affective Aspects of Psychedelic Use in a Naturalistic Setting: A Linguistic Analysis of Online Experience Reports.
    Žuljević MF; Mijatović A; Marušić SL; Kudrjavets G; Buljan I; Hren D
    J Psychoactive Drugs; 2023 Nov; ():1-13. PubMed ID: 37921118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An introduction to psychedelic neuroscience.
    Calvey T; Howells FM
    Prog Brain Res; 2018; 242():1-23. PubMed ID: 30471677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs.
    Tagliazucchi E
    Front Pharmacol; 2022; 13():812227. PubMed ID: 35392561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety.
    Davis AK; Barrett FS; Griffiths RR
    J Contextual Behav Sci; 2020 Jan; 15():39-45. PubMed ID: 32864325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cessation and reduction in alcohol consumption and misuse after psychedelic use.
    Garcia-Romeu A; Davis AK; Erowid F; Erowid E; Griffiths RR; Johnson MW
    J Psychopharmacol; 2019 Sep; 33(9):1088-1101. PubMed ID: 31084460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.